Nichols & Pratt Advisers sold 7,627 CVS Health shares in Q1, lowering its stake by 6.9%, SEC filings show. The firm now holds ...

CVS Health (CVS) ended the recent trading session at $66.60, demonstrating a -4.28% change from the preceding day's closing price. This change lagged the S&P 500's 0.48% gain on the day. Meanwhile, ...

Strong pharmacy drug mix, flu season and store optimization power CVS Health's PCW gains. Will the momentum continue?

CVS Health (CVS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some ...

In the assessment of 12-month price targets, analysts unveil insights for CVS Health, presenting an average target of $79.0, ...

One way to get an idea of the market sentiment on a stock is to check its rate of institutional ownership. In the case of CVS ...

Mirae Asset Global Investments Co. Ltd. juiced up its stake in CVS Health Corporation by a healthy 12.6%, showcasing a robust ...

CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Sri Narasimhan, vice president, head of enterprise, customer experience and insights at CVS Health, discusses how patient ...

For CVS Health CVS, the key to building customer trust is to enhance access to life-changing medications and also make them affordable. Beginning July 1, the company’s Pharmacy Benefit Manager (“PBM”) ...